Biggest News Aggregation in the World
📰 Efficacy Analysis Population News

Efficacy Analysis Population News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Efficacy Analysis Population. Real-time updates on events, politics, business and more.

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Invest

− First results from LIGHTHOUSE trial presented at 23rd Annual Scientific Meeting in Urologic Oncology (SUO) –MONROE TOWNSHIP, N.J. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today...
United States United Kingdom San Diego Scintomics Gmb Davide Gauden Brianf Chapin

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

- First results from LIGHTHOUSE trial presented at 23rd Annual Scientific Meeting in Urologic Oncology (SUO) - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and
United States United Kingdom San Diego Scintomics Gmb Kostenloser Wertpapierhandel Davide Gauden

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

- Oral presentation based on Late-breaking Abstract featured at American Urological Association's 2022 Annual Meeting (AUA2022) - Blue Earth Diagnostics, a Bracco company and recognized leader in
United States United Kingdom Scintomics Gmb Kostenloser Wertpapierhandel Georgina Mowatt Markt Fleming

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer - read this article along with other careers information, tips and advice on BioSpace
United States Scintomics Gmb Markt Fleming Davide Gauden Study Group Drug Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science